Clinical Trial: Long-term Follow-up (LTFU) of Participants Who Received Azer-Cel

U.S., May 12 -- ClinicalTrials.gov registry received information related to the study (NCT07577583) titled 'Long-term Follow-up (LTFU) of Participants Who Received Azer-Cel' on April 27.

Brief Summary: The main objective of this study is to collect data on the long-term safety of azer-cel, primarily through the capture of clinical events of interest (CEI) for up to 15 years following participation in TG-Azercel -101 study.

Study Start Date: May 01, 2027

Study Type: OBSERVATIONAL

Condition: B-cell Mediated Autoimmune Disorders

Intervention: OTHER: No Intervention

No Intervention

Recruitment Status: NOT_YET_RECRUITING

Sponsor: TG Therapeutics, Inc.

Disclaimer: Curated by HT Syndication....